|
|
3960 Point Eden Way
Hayward, CA 94545 USA
phone:510.512.7200
fax:510.786.1116
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.acologix.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapeutics in the the osteo-renal area. |
|
| Management |
| Yoshinari Kumagai, President, Chief Executive Officer and Director; David M. Rosen, Ph.D., Senior Vice President, Research and Development; Dawn McGuire, M.D., Chief Medical Officer; R. Scott Greer, Chairman of the Board; Daniel F. Hoth, M.D., Biotechnology and Pharmaceutical Consultant |
| |
|
|
| |
|
| Keywords |
| uremic pruritus, itching indications, unmet medical, parathyroid, hormone |
|
|
|
| Description |
|
Acologix, Inc. is a biology-based company focusing on the identification and development of novel therapeutics. The current primary product candidates in Acologix target the treatment of the diseases and disorders in "osteo-renal" area that are osteoporosis, periodontal/dental diseases, and chronic renal failure. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members